<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20240415203807&amp;utm_source=Chrome&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;v=2.18.0.post9+e462414&amp;fc=20230708114047&amp;utm_campaign=pubmed-2
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20240415203807&amp;utm_source=Chrome&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;v=2.18.0.post9+e462414&amp;fc=20230708114047&amp;utm_campaign=pubmed-2" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Tue, 16 Apr 2024 00:38:07 +0000</lastbuilddate>
<pubDate>Mon, 15 Apr 2024 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>Home-based fitness training: chicken soup for the ACHD soul?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38621021/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240415203807&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Apr 15:ehae142. doi: 10.1093/eurheartj/ehae142. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38621021/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240415203807&v=2.18.0.post9+e462414">38621021</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae142>10.1093/eurheartj/ehae142</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38621021</guid>
<pubDate>Mon, 15 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Keri M Shafer</dc:creator>
<dc:creator>Anne Marie Valente</dc:creator>
<dc:date>2024-04-15</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Home-based fitness training: chicken soup for the ACHD soul?</dc:title>
<dc:identifier>pmid:38621021</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae142</dc:identifier>
</item>
<item>
<title>From the Literature</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38620093/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240415203807&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Dec 12;148(24):1974-1975. doi: 10.1161/CIRCULATIONAHA.123.067760. Epub 2023 Dec 11.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38620093/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240415203807&v=2.18.0.post9+e462414">38620093</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.067760>10.1161/CIRCULATIONAHA.123.067760</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38620093</guid>
<pubDate>Mon, 15 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Tracy Hampton</dc:creator>
<dc:date>2024-04-15</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>From the Literature</dc:title>
<dc:identifier>pmid:38620093</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.067760</dc:identifier>
</item>
<item>
<title>Correction to: 2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Education, Implementation, and Teams; and First Aid Task Forces</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38620091/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240415203807&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 16;149(16):e1128. doi: 10.1161/CIR.0000000000001242. Epub 2024 Apr 15.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38620091/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240415203807&v=2.18.0.post9+e462414">38620091</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001242>10.1161/CIR.0000000000001242</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38620091</guid>
<pubDate>Mon, 15 Apr 2024 06:00:00 -0400</pubDate>
<dc:date>2024-04-15</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: 2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Education, Implementation, and Teams; and First Aid Task Forces</dc:title>
<dc:identifier>pmid:38620091</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001242</dc:identifier>
</item>
<item>
<title>Health-Related Quality of Life Instruments in Chronic Limb-Threatening Ischemia: Evolution of Defining Quality of Life in a Complex Disease State</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38620090/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240415203807&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 16;149(16):1254-1257. doi: 10.1161/CIRCULATIONAHA.123.067812. Epub 2024 Apr 15.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38620090/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240415203807&v=2.18.0.post9+e462414">38620090</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.067812>10.1161/CIRCULATIONAHA.123.067812</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38620090</guid>
<pubDate>Mon, 15 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Jennifer A Rymer</dc:creator>
<dc:creator>Manesh R Patel</dc:creator>
<dc:date>2024-04-15</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Health-Related Quality of Life Instruments in Chronic Limb-Threatening Ischemia: Evolution of Defining Quality of Life in a Complex Disease State</dc:title>
<dc:identifier>pmid:38620090</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.067812</dc:identifier>
</item>
<item>
<title>Correction to: Cytokine mRNA Degradation in Cardiomyocytes Restrains Sterile Inflammation in Pressure-Overloaded Hearts</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38620089/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240415203807&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 16;149(16):e1131. doi: 10.1161/CIR.0000000000001248. Epub 2024 Apr 15.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38620089/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240415203807&v=2.18.0.post9+e462414">38620089</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001248>10.1161/CIR.0000000000001248</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38620089</guid>
<pubDate>Mon, 15 Apr 2024 06:00:00 -0400</pubDate>
<dc:date>2024-04-15</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: Cytokine mRNA Degradation in Cardiomyocytes Restrains Sterile Inflammation in Pressure-Overloaded Hearts</dc:title>
<dc:identifier>pmid:38620089</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001248</dc:identifier>
</item>
<item>
<title>Correction to: Effects of Synchronizing Foot Strike and Cardiac Phase on Exercise Hemodynamics in Patients With Cardiac Resynchronization Therapy: A Within-Subjects Pilot Study to Fine-Tune Cardio-Locomotor Coupling for Heart Failure</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38620088/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240415203807&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 16;149(16):e1130. doi: 10.1161/CIR.0000000000001249. Epub 2024 Apr 15.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38620088/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240415203807&v=2.18.0.post9+e462414">38620088</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001249>10.1161/CIR.0000000000001249</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38620088</guid>
<pubDate>Mon, 15 Apr 2024 06:00:00 -0400</pubDate>
<dc:date>2024-04-15</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: Effects of Synchronizing Foot Strike and Cardiac Phase on Exercise Hemodynamics in Patients With Cardiac Resynchronization Therapy: A Within-Subjects Pilot Study to Fine-Tune Cardio-Locomotor Coupling for Heart Failure</dc:title>
<dc:identifier>pmid:38620088</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001249</dc:identifier>
</item>
<item>
<title>Correction to: Toward Heart-Healthy and Sustainable Cities: A Policy Statement From the American Heart Association</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38620087/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240415203807&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 16;149(16):e1129. doi: 10.1161/CIR.0000000000001244. Epub 2024 Apr 15.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38620087/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240415203807&v=2.18.0.post9+e462414">38620087</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001244>10.1161/CIR.0000000000001244</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38620087</guid>
<pubDate>Mon, 15 Apr 2024 06:00:00 -0400</pubDate>
<dc:date>2024-04-15</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: Toward Heart-Healthy and Sustainable Cities: A Policy Statement From the American Heart Association</dc:title>
<dc:identifier>pmid:38620087</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001244</dc:identifier>
</item>
<item>
<title>The Efficacy and Safety of Andexanet Alfa in Patients With Acute Gastrointestinal Bleeding While Taking Factor Xa Inhibitors: An ANNEXA-4 Subanalysis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38620086/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240415203807&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 16;149(16):1315-1318. doi: 10.1161/CIRCULATIONAHA.123.066933. Epub 2024 Apr 15.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38620086/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240415203807&v=2.18.0.post9+e462414">38620086</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.066933>10.1161/CIRCULATIONAHA.123.066933</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38620086</guid>
<pubDate>Mon, 15 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Deborah M Siegal</dc:creator>
<dc:creator>Nauzer Forbes</dc:creator>
<dc:creator>John Eikelboom</dc:creator>
<dc:creator>Jan Beyer-Westendorf</dc:creator>
<dc:creator>Alexander T Cohen</dc:creator>
<dc:creator>Lizhen Xu</dc:creator>
<dc:creator>Stuart J Connolly</dc:creator>
<dc:creator>Mark Crowther</dc:creator>
<dc:date>2024-04-15</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>The Efficacy and Safety of Andexanet Alfa in Patients With Acute Gastrointestinal Bleeding While Taking Factor Xa Inhibitors: An ANNEXA-4 Subanalysis</dc:title>
<dc:identifier>pmid:38620086</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.066933</dc:identifier>
</item>
<item>
<title>Artificial Intelligence and Machine Learning in Cardiology</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38620085/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240415203807&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 16;149(16):1235-1237. doi: 10.1161/CIRCULATIONAHA.123.065469. Epub 2024 Apr 15.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38620085/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240415203807&v=2.18.0.post9+e462414">38620085</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065469>10.1161/CIRCULATIONAHA.123.065469</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38620085</guid>
<pubDate>Mon, 15 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Rahul C Deo</dc:creator>
<dc:date>2024-04-15</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Artificial Intelligence and Machine Learning in Cardiology</dc:title>
<dc:identifier>pmid:38620085</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.065469</dc:identifier>
</item>
<item>
<title>Letter by Mayer Regarding Article, "Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38620084/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240415203807&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 16;149(16):e1109-e1110. doi: 10.1161/CIRCULATIONAHA.123.067538. Epub 2024 Apr 15.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38620084/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240415203807&v=2.18.0.post9+e462414">38620084</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.067538>10.1161/CIRCULATIONAHA.123.067538</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38620084</guid>
<pubDate>Mon, 15 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Martin Mayer</dc:creator>
<dc:date>2024-04-15</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Letter by Mayer Regarding Article, "Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants"</dc:title>
<dc:identifier>pmid:38620084</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.067538</dc:identifier>
</item>
<item>
<title>Response by Aggarwal et al to Letter Regarding Article, "Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38620083/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240415203807&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 16;149(16):e1111-e1112. doi: 10.1161/CIRCULATIONAHA.123.068239. Epub 2024 Apr 15.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38620083/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240415203807&v=2.18.0.post9+e462414">38620083</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.068239>10.1161/CIRCULATIONAHA.123.068239</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38620083</guid>
<pubDate>Mon, 15 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Rahul Aggarwal</dc:creator>
<dc:creator>Christian T Ruff</dc:creator>
<dc:creator>Saverio Virdone</dc:creator>
<dc:creator>Sylvie Perreault</dc:creator>
<dc:creator>Ajay K Kakkar</dc:creator>
<dc:creator>Michael G Palazzolo</dc:creator>
<dc:creator>Marc Dorais</dc:creator>
<dc:creator>Gloria Kayani</dc:creator>
<dc:creator>Robert W Yeh</dc:creator>
<dc:date>2024-04-15</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Response by Aggarwal et al to Letter Regarding Article, "Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants"</dc:title>
<dc:identifier>pmid:38620083</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.068239</dc:identifier>
</item>
<item>
<title>Accelerated Risk-Based Implementation of Guideline-Directed Medical Therapy for Type 2 Diabetes and Chronic Kidney Disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38620082/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240415203807&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 16;149(16):1238-1240. doi: 10.1161/CIRCULATIONAHA.123.068524. Epub 2024 Apr 15.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38620082/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240415203807&v=2.18.0.post9+e462414">38620082</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.068524>10.1161/CIRCULATIONAHA.123.068524</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38620082</guid>
<pubDate>Mon, 15 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Brendon L Neuen</dc:creator>
<dc:creator>Katherine R Tuttle</dc:creator>
<dc:creator>Muthiah Vaduganathan</dc:creator>
<dc:date>2024-04-15</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Accelerated Risk-Based Implementation of Guideline-Directed Medical Therapy for Type 2 Diabetes and Chronic Kidney Disease</dc:title>
<dc:identifier>pmid:38620082</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.068524</dc:identifier>
</item>
<item>
<title>Nanopore Detection of METTL3-Dependent m6A-Modified mRNA Reveals a New Mechanism Regulating Cardiomyocyte Mitochondrial Metabolism</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38620081/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240415203807&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 16;149(16):1319-1322. doi: 10.1161/CIRCULATIONAHA.123.066473. Epub 2024 Apr 15.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38620081/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240415203807&v=2.18.0.post9+e462414">38620081</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.066473>10.1161/CIRCULATIONAHA.123.066473</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38620081</guid>
<pubDate>Mon, 15 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Charles P Rabolli</dc:creator>
<dc:creator>Isabel S Naarmann-de Vries</dc:creator>
<dc:creator>Catherine A Makarewich</dc:creator>
<dc:creator>Kedryn K Baskin</dc:creator>
<dc:creator>Christoph Dieterich</dc:creator>
<dc:creator>Federica Accornero</dc:creator>
<dc:date>2024-04-15</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Nanopore Detection of METTL3-Dependent m6A-Modified mRNA Reveals a New Mechanism Regulating Cardiomyocyte Mitochondrial Metabolism</dc:title>
<dc:identifier>pmid:38620081</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.066473</dc:identifier>
</item>
<item>
<title>The Urban Environment and Cardiometabolic Health</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38620080/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240415203807&amp;v=2.18.0.post9+e462414
      <description>Urban environments contribute substantially to the rising burden of cardiometabolic diseases worldwide. Cities are complex adaptive systems that continually exchange resources, shaping exposures relevant to human health such as air pollution, noise, and chemical exposures. In addition, urban infrastructure and provisioning systems influence multiple domains of health risk, including behaviors, psychological stress, pollution, and nutrition through various pathways (eg, physical inactivity, air...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 16;149(16):1298-1314. doi: 10.1161/CIRCULATIONAHA.123.067461. Epub 2024 Apr 15.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Urban environments contribute substantially to the rising burden of cardiometabolic diseases worldwide. Cities are complex adaptive systems that continually exchange resources, shaping exposures relevant to human health such as air pollution, noise, and chemical exposures. In addition, urban infrastructure and provisioning systems influence multiple domains of health risk, including behaviors, psychological stress, pollution, and nutrition through various pathways (eg, physical inactivity, air pollution, noise, heat stress, food systems, the availability of green space, and contaminant exposures). Beyond cardiometabolic health, city design may also affect climate change through energy and material consumption that share many of the same drivers with cardiometabolic diseases. Integrated spatial planning focusing on developing sustainable compact cities could simultaneously create heart-healthy and environmentally healthy city designs. This article reviews current evidence on the associations between the urban exposome (totality of exposures a person experiences, including environmental, occupational, lifestyle, social, and psychological factors) and cardiometabolic diseases within a systems science framework, and examines urban planning principles (eg, connectivity, density, diversity of land use, destination accessibility, and distance to transit). We highlight critical knowledge gaps regarding built-environment feature thresholds for optimizing cardiometabolic health outcomes. Last, we discuss emerging models and metrics to align urban development with the dual goals of mitigating cardiometabolic diseases while reducing climate change through cross-sector collaboration, governance, and community engagement. This review demonstrates that cities represent crucial settings for implementing policies and interventions to simultaneously tackle the global epidemics of cardiovascular disease and climate change.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38620080/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240415203807&v=2.18.0.post9+e462414">38620080</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.067461>10.1161/CIRCULATIONAHA.123.067461</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38620080</guid>
<pubDate>Mon, 15 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Sanjay Rajagopalan</dc:creator>
<dc:creator>Armando Vergara-Martel</dc:creator>
<dc:creator>Jeffrey Zhong</dc:creator>
<dc:creator>Haitham Khraishah</dc:creator>
<dc:creator>Mikhail Kosiborod</dc:creator>
<dc:creator>Ian J Neeland</dc:creator>
<dc:creator>Jean-Eudes Dazard</dc:creator>
<dc:creator>Zhuo Chen</dc:creator>
<dc:creator>Thomas Munzel</dc:creator>
<dc:creator>Robert D Brook</dc:creator>
<dc:creator>Mark Nieuwenhuijsen</dc:creator>
<dc:creator>Peter Hovmand</dc:creator>
<dc:creator>Sadeer Al-Kindi</dc:creator>
<dc:date>2024-04-15</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>The Urban Environment and Cardiometabolic Health</dc:title>
<dc:identifier>pmid:38620080</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.067461</dc:identifier>
</item>
<item>
<title>Obesity: an overlooked player in cardiological practice and the need for urgent action</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38620068/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240415203807&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Apr 15:ehad875. doi: 10.1093/eurheartj/ehad875. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38620068/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240415203807&v=2.18.0.post9+e462414">38620068</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad875>10.1093/eurheartj/ehad875</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38620068</guid>
<pubDate>Mon, 15 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Armando Ferrera</dc:creator>
<dc:creator>Allegra Battistoni</dc:creator>
<dc:creator>Massimo Volpe</dc:creator>
<dc:date>2024-04-15</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Obesity: an overlooked player in cardiological practice and the need for urgent action</dc:title>
<dc:identifier>pmid:38620068</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad875</dc:identifier>
</item>
<item>
<title>Highlights From the &lt;em>;Circulation&lt;/em>; Family of Journals</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38620067/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240415203807&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Dec 19;148(25):2058-2063. doi: 10.1161/CIRCULATIONAHA.123.068005. Epub 2023 Dec 18.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38620067/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240415203807&v=2.18.0.post9+e462414">38620067</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.068005>10.1161/CIRCULATIONAHA.123.068005</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38620067</guid>
<pubDate>Mon, 15 Apr 2024 06:00:00 -0400</pubDate>
<dc:date>2024-04-15</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Highlights From the &lt;em>;Circulation&lt;/em>; Family of Journals</dc:title>
<dc:identifier>pmid:38620067</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.068005</dc:identifier>
</item>
<item>
<title>Coexisting atrial fibrillation and cancer: time trends and associations with mortality in a nationwide Dutch study</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38619538/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240415203807&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Atrial fibrillation and cancer were associated bidirectionally and were increasingly coexisting, but AF risk varied by cancer type. Coexisting AF and cancer were negatively associated with survival.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Apr 15:ehae222. doi: 10.1093/eurheartj/ehae222. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: Coexisting atrial fibrillation (AF) and cancer challenge the management of both. The aim of the study is to comprehensively provide the epidemiology of coexisting AF and cancer.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Using Dutch nationwide statistics, individuals with incident AF (n = 320 139) or cancer (n = 472 745) were identified during the period 2015-19. Dutch inhabitants without a history of AF (n = 320 135) or cancer (n = 472 741) were matched as control cohorts by demographic characteristics. Prevalence of cancer/AF at baseline, 1-year risk of cancer/AF diagnosis, and their time trends were determined. The association of cancer/AF diagnosis with all-cause mortality among those with AF/cancer was estimated by using time-dependent Cox regression.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The rate of prevalence of cancer in the AF cohort was 12.6% (increasing from 11.9% to 13.2%) compared with 5.6% in the controls; 1-year cancer risk was 2.5% (stable over years) compared with 1.8% in the controls [adjusted hazard ratio (aHR) 1.52, 95% confidence interval (CI) 1.46-1.58], which was similar by cancer type. The rate of prevalence of AF in the cancer cohort was 7.5% (increasing from 6.9% to 8.2%) compared with 4.3% in the controls; 1-year AF risk was 2.8% (stable over years) compared with 1.2% in the controls (aHR 2.78, 95% CI 2.69-2.87), but cancers of the oesophagus, lung, stomach, myeloma, and lymphoma were associated with higher hazards of AF than other cancer types. Both cancer diagnosed after incident AF (aHR 7.77, 95% CI 7.45-8.11) and AF diagnosed after incident cancer (aHR 2.55, 95% CI 2.47-2.63) were associated with all-cause mortality, but the strength of the association varied by cancer type.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Atrial fibrillation and cancer were associated bidirectionally and were increasingly coexisting, but AF risk varied by cancer type. Coexisting AF and cancer were negatively associated with survival.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38619538/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240415203807&v=2.18.0.post9+e462414">38619538</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae222>10.1093/eurheartj/ehae222</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38619538</guid>
<pubDate>Mon, 15 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Qingui Chen</dc:creator>
<dc:creator>Nienke van Rein</dc:creator>
<dc:creator>Tom van der Hulle</dc:creator>
<dc:creator>Julius C Heemelaar</dc:creator>
<dc:creator>Serge A Trines</dc:creator>
<dc:creator>Henri H Versteeg</dc:creator>
<dc:creator>Frederikus A Klok</dc:creator>
<dc:creator>Suzanne C Cannegieter</dc:creator>
<dc:date>2024-04-15</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Coexisting atrial fibrillation and cancer: time trends and associations with mortality in a nationwide Dutch study</dc:title>
<dc:identifier>pmid:38619538</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae222</dc:identifier>
</item>
<item>
<title>In This Issue</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38619180/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240415203807&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Apr 12;134(8):951. doi: 10.1161/RES.0000000000000669. Epub 2024 Apr 11.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38619180/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240415203807&v=2.18.0.post9+e462414">38619180</a> | DOI:<a href=https://doi.org/10.1161/RES.0000000000000669>10.1161/RES.0000000000000669</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38619180</guid>
<pubDate>Mon, 15 Apr 2024 06:00:00 -0400</pubDate>
<dc:date>2024-04-15</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>In This Issue</dc:title>
<dc:identifier>pmid:38619180</dc:identifier>
<dc:identifier>doi:10.1161/RES.0000000000000669</dc:identifier>
</item>
<item>
<title>Environmental Exposures and Pediatric Cardiology: A Scientific Statement From the American Heart Association</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38618723/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240415203807&amp;v=2.18.0.post9+e462414
      <description>Environmental toxicants and pollutants are causes of adverse health consequences, including well-established associations between environmental exposures and cardiovascular diseases. Environmental degradation is widely prevalent and has a long latency period between exposure and health outcome, potentially placing a large number of individuals at risk of these health consequences. Emerging evidence suggests that environmental exposures in early life may be key risk factors for cardiovascular...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 15. doi: 10.1161/CIR.0000000000001234. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Environmental toxicants and pollutants are causes of adverse health consequences, including well-established associations between environmental exposures and cardiovascular diseases. Environmental degradation is widely prevalent and has a long latency period between exposure and health outcome, potentially placing a large number of individuals at risk of these health consequences. Emerging evidence suggests that environmental exposures in early life may be key risk factors for cardiovascular conditions across the life span. Children are a particularly sensitive population for the detrimental effects of environmental toxicants and pollutants given the long-term cumulative effects of early-life exposures on health outcomes, including congenital heart disease, acquired cardiac diseases, and accumulation of cardiovascular disease risk factors. This scientific statement highlights representative examples for each of these cardiovascular disease subtypes and their determinants, focusing specifically on the associations between climate change and congenital heart disease, airborne particulate matter and Kawasaki disease, blood lead levels and blood pressure, and endocrine-disrupting chemicals with cardiometabolic risk factors. Because children are particularly dependent on their caregivers to address their health concerns, this scientific statement highlights the need for clinicians, research scientists, and policymakers to focus more on the linkages of environmental exposures with cardiovascular conditions in children and adolescents.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38618723/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240415203807&v=2.18.0.post9+e462414">38618723</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001234>10.1161/CIR.0000000000001234</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38618723</guid>
<pubDate>Mon, 15 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Justin P Zachariah</dc:creator>
<dc:creator>Pei-Ni Jone</dc:creator>
<dc:creator>Andrew O Agbaje</dc:creator>
<dc:creator>Heather H Ryan</dc:creator>
<dc:creator>Leonardo Trasande</dc:creator>
<dc:creator>Wei Perng</dc:creator>
<dc:creator>Shohreh F Farzan</dc:creator>
<dc:creator>American Heart Association Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; Council on Lifestyle and Cardiometabolic Health; and Council on Clinical Cardiology</dc:creator>
<dc:date>2024-04-15</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Environmental Exposures and Pediatric Cardiology: A Scientific Statement From the American Heart Association</dc:title>
<dc:identifier>pmid:38618723</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001234</dc:identifier>
</item>
<item>
<title>Buffering Mechanism in Aortic Arch Artery Formation and Congenital Heart Disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38618720/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240415203807&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Our studies uncover a novel buffering mechanism underlying the resiliency of PAA development and remodeling.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Apr 15. doi: 10.1161/CIRCRESAHA.123.322767. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: The resiliency of embryonic development to genetic and environmental perturbations has been long appreciated; however, little is known about the mechanisms underlying the robustness of developmental processes. Aberrations resulting in neonatal lethality are exemplified by congenital heart disease arising from defective morphogenesis of pharyngeal arch arteries (PAAs) and their derivatives.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: To uncover mechanisms underlying the robustness of PAA morphogenesis.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS AND RESULTS: The second heart field (SHF) gives rise to the PAA endothelium. Here, we show that the number of SHF-derived endothelial cells (ECs) is regulated by <i>VEGFR2</i> (vascular endothelial growth factor receptor 2) and <i>Tbx1</i>. Remarkably, when the SHF-derived EC number is decreased, PAA development can be rescued by the compensatory endothelium. Blocking such compensatory response leads to embryonic demise. To determine the source of compensating ECs and mechanisms regulating their recruitment, we investigated 3-dimensional EC connectivity, EC fate, and gene expression. Our studies demonstrate that the expression of VEGFR2 by the SHF is required for the differentiation of SHF-derived cells into PAA ECs. The deletion of 1 VEGFR2 allele (<i>VEGFR2</i><sup><i>SHF-HET</i></sup>) reduces SHF contribution to the PAA endothelium, while the deletion of both alleles (<i>VEGFR2</i><sup><i>SHF-KO</i></sup>) abolishes it. The decrease in SHF-derived ECs in VEGFR2<sup>SHF-HET</sup> and <i>VEGFR2</i><sup><i>SHF-KO</i></sup> embryos is complemented by the recruitment of ECs from the nearby veins. Compensatory ECs contribute to PAA derivatives, giving rise to the endothelium of the aortic arch and the ductus in <i>VEGFR2</i><sup><i>SHF-KO</i></sup> mutants. Blocking the compensatory response in <i>VEGFR2</i><sup><i>SHF-KO</i></sup> mutants results in embryonic lethality shortly after mid-gestation. The compensatory ECs are absent in <i>Tbx1</i><sup><i>±</i></sup> embryos, a model for 22q11 deletion syndrome, leading to unpredictable arch artery morphogenesis and congenital heart disease. <i>Tbx1</i> regulates the recruitment of the compensatory endothelium in an SHF-noncell-autonomous manner.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Our studies uncover a novel buffering mechanism underlying the resiliency of PAA development and remodeling.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38618720/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240415203807&v=2.18.0.post9+e462414">38618720</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.322767>10.1161/CIRCRESAHA.123.322767</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38618720</guid>
<pubDate>Mon, 15 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>AnnJosette Ramirez</dc:creator>
<dc:creator>Christina A Vyzas</dc:creator>
<dc:creator>Huaning Zhao</dc:creator>
<dc:creator>Kevin Eng</dc:creator>
<dc:creator>Karl Degenhardt</dc:creator>
<dc:creator>Sophie Astrof</dc:creator>
<dc:date>2024-04-15</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Buffering Mechanism in Aortic Arch Artery Formation and Congenital Heart Disease</dc:title>
<dc:identifier>pmid:38618720</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.322767</dc:identifier>
</item>
<item>
<title>Inhibition of the mPTP and Lipid Peroxidation Is Additively Protective Against I/R Injury</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38618716/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240415203807&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: In the present study, we have investigated the relationship between Ca^(2+) and ROS, and how they individually or synergistically induce mitochondrial swelling. Our findings suggest that Ca^(2+) mediates mitochondrial damage through the opening of the mPTP, although ROS mediates its damaging effects through lipid peroxidation. However, subtoxic levels both Ca^(2+) and ROS can induce mPTP-mediated mitochondrial damage. Targeting both of these triggers to preserve mitochondria...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Apr 15. doi: 10.1161/CIRCRESAHA.123.323882. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: During myocardial ischemia/reperfusion (I/R) injury, high levels of matrix Ca<sup>2+</sup> and reactive oxygen species (ROS) induce the opening of the mitochondrial permeability transition pore (mPTP), which causes mitochondrial dysfunction and ultimately necrotic death. However, the mechanisms of how these triggers individually or cooperatively open the pore have yet to be determined.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Here, we use a combination of isolated mitochondrial assays and in vivo I/R surgery in mice. We challenged isolated liver and heart mitochondria with Ca<sup>2+</sup>, ROS, and Fe<sup>2+</sup> to induce mitochondrial swelling. Using inhibitors of the mPTP (cyclosporine A or ADP) lipid peroxidation (Fer-1 [ferrostatin-1], mitoquinone), we determined how the triggers elicit mitochondrial damage. Additionally, we used the combination of inhibitors during I/R injury in mice to determine if dual inhibition of these pathways is additivity protective.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: In the absence of Ca<sup>2+</sup>, we determined that ROS fails to trigger mPTP opening. Instead, high levels of ROS induce mitochondrial dysfunction and rupture independently of the mPTP through lipid peroxidation. As expected, Ca<sup>2+</sup> in the absence of ROS induces mPTP-dependent mitochondrial swelling. Subtoxic levels of ROS and Ca<sup>2+</sup> synergize to induce mPTP opening. Furthermore, this synergistic form of Ca<sup>2+</sup>- and ROS-induced mPTP opening persists in the absence of CypD (cyclophilin D), suggesting the existence of a CypD-independent mechanism for ROS sensitization of the mPTP. These ex vivo findings suggest that mitochondrial dysfunction may be achieved by multiple means during I/R injury. We determined that dual inhibition of the mPTP and lipid peroxidation is significantly more protective against I/R injury than individually targeting either pathway alone.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: In the present study, we have investigated the relationship between Ca<sup>2+</sup> and ROS, and how they individually or synergistically induce mitochondrial swelling. Our findings suggest that Ca<sup>2+</sup> mediates mitochondrial damage through the opening of the mPTP, although ROS mediates its damaging effects through lipid peroxidation. However, subtoxic levels both Ca<sup>2+</sup> and ROS can induce mPTP-mediated mitochondrial damage. Targeting both of these triggers to preserve mitochondria viability unveils a highly effective therapeutic approach for mitigating I/R injury.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38618716/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240415203807&v=2.18.0.post9+e462414">38618716</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.323882>10.1161/CIRCRESAHA.123.323882</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38618716</guid>
<pubDate>Mon, 15 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Arielys Mendoza</dc:creator>
<dc:creator>Pooja Patel</dc:creator>
<dc:creator>Dexter Robichaux</dc:creator>
<dc:creator>Daniel Ramirez</dc:creator>
<dc:creator>Jason Karch</dc:creator>
<dc:date>2024-04-15</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Inhibition of the mPTP and Lipid Peroxidation Is Additively Protective Against I/R Injury</dc:title>
<dc:identifier>pmid:38618716</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.323882</dc:identifier>
</item>





























</channel>
</rss>